Tonix Pharmaceuticals Holding Corp

Healthcare · Biotechnology

9.90$ +1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Tonix Pharmaceuticals Holding Corp (TNXP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 254 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TNXP
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	30	28	24	36	31	27	21	18	16	26	20	15	12	15	34	58	68	98	184	189	215	241	224	276	243	226	179	160	139	154	135	70	95	163	193	187	252	277	258	254
Current Assets	29	27	23	35	30	26	21	18	16	26	19	14	12	14	33	58	62	88	173	177	195	189	153	192	151	131	84	51	31	48	30	25	51	119	150	144	208	229	207	203
Cash	16	19	20	34	29	25	19	17	15	25	16	12	10	11	31	55	56	77	164	166	183	179	140	145	140	120	72	26	6.9	25	7.0	4.2	28	99	132	125	190	208	185	176
Cash & Short-Term Investments	27	26	22	34	29	25	19	17	15	25	16	12	10	11	31	55	56	77	164	166	183	179	140	145	140	120	72	26	6.9	–	7.0	4.2	28	99	132	125	190	208	185	176
Receivables	–	0.4	0.4	–	–	0.5	0.5	–	–	0.5	0.5	–	–	1.0	1.0	–	–	7.6	7.6	–	–	7.7	–	–	–	8.0	–	–	1.6	0.0	4.6	3.3	4.0	7.9	4.8	7.9	3.5	9.8	8.8	12
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	-1.0	–	–	–	-7.6	–	–	–	-7.7	–	–	–	-8.0	–	14	13	14	12	9.5	7.9	8.4	8.1	6.0	5.7	6.0	3.6	5.7
Property, Plant & Equipment	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.8	9.1	12	18	51	70	84	91	95	94	97	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	–	1.0	1.0	1.0	1.0	0.0	0.0	0.0	–	–	–	–	–	–
Intangible Assets	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	–	–	–	0.1	–	10	10.0	9.7	9.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Total Liabilities	2.7	2.1	1.8	1.9	1.9	2.1	2.4	2.5	2.3	2.7	2.2	2.2	2.4	5.1	2.7	4.8	5.0	11	6.6	8.7	13	22	16	16	14	19	14	19	18	49	27	28	21	23	12	19	21	32	31	32
Current Liabilities	2.6	2.1	1.8	1.8	1.8	2.1	2.4	2.5	2.3	2.7	2.0	2.0	2.4	5.1	2.7	4.7	4.4	9.8	6.0	8.1	12	22	15	16	13	18	13	18	18	19	20	22	15	18	12	19	21	31	30	31
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	0.8	0.9	0.8	0.4	0.3	0.3	0.5	0.6	0.4	0.5	0.6	0.5	0.4	0.5	0.5	0.4	0.4	0.4	0.4	–	3.1	3.4	3.1	0.3	0.2	0.2	0.2	0.1	0.2	0.3
Accounts Payable	0.9	2.1	0.8	1.2	1.4	1.3	1.3	1.6	1.1	1.4	1.1	1.0	1.1	3.1	1.4	3.2	1.8	4.6	2.9	3.4	8.0	13	9.4	9.6	4.6	8.1	8.0	7.7	7.8	3.8	6.6	10	3.9	4.5	4.2	7.8	8.5	8.1	9.6	9.1
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	0.2	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	6.6	6.2	5.7	5.2	4.7	–	–	–	–	–	–
Shareholders' Equity	27	25	22	34	29	25	19	16	14	24	18	13	9.9	9.4	31	54	63	88	177	180	202	219	208	260	229	207	165	140	121	106	108	42	74	140	180	168	231	245	227	222
Retained Earnings	-134	-141	-146	-151	-157	-162	-169	-175	-181	-188	-195	-201	-208	-217	-224	-239	-251	-268	-288	-312	-330	-360	-386	-409	-438	-470	-517	-545	-573	-601	-616	-694	-709	-731	-748	-776	-808	-855	-895	-935
Shares Outstanding	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	5.9	7.3	8.9	8.5	14	17

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings